4.6 Article

Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids

Mohammed A. Farhan et al.

MEDICAL MYCOLOGY (2019)

Letter Respiratory System

Inhaled Corticosteroids and Systemic or Topical Antifungal Therapy: A Symmetry Analysis

Daniel Pilsgaard Henriksen et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)

Article Dentistry, Oral Surgery & Medicine

Candida concentrations determined following concentrated oral rinse culture reflect clinical oral signs

Hiroaki Tooyama et al.

BMC ORAL HEALTH (2015)

Article Microbiology

Clinical Appearance of Oral Candida Infection and Therapeutic Strategies

Shankargouda Patil et al.

FRONTIERS IN MICROBIOLOGY (2015)

Review Dentistry, Oral Surgery & Medicine

Risk factors for periodontal disease

Robert J. Genco et al.

PERIODONTOLOGY 2000 (2013)

Article Medicine, General & Internal

Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients

Safia A. Al-Attas et al.

ANNALS OF SAUDI MEDICINE (2010)

Article Biochemistry & Molecular Biology

Aspects of the steroid response in fungi

Bronislava Cresnar et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2009)

Article Allergy

Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis

Gary S. Rachelefsky et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)